Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
21 | DE file number | DAKZ | 601 49 782.1 |
96 | EP file number | EAKZ | 10 18 0857.4 |
97 | EP publication number | EPN | 2363139 |
54 | Designation/title | TI | Verfahren zur Steigerung der Klasse I Darstellung von exogenen Antigenen durch humane dendritische Zellen |
51 | IPC main class | ICM (ICMV) | A61K 39/00 (2006.01) |
22 | DE application date | DAT | May 11, 2001 |
96 | EP application date | EAT | May 11, 2001 |
43 | Date of first publication | OT | Sep 7, 2011 |
| Date of publication of grant | PET | Mar 2, 2016 |
71/73 | Applicant/owner | INH | NorthWest Biotherapeutics, Inc., Bothell, Wash., US |
72 | Inventor | IN | Salgaller, Michael L., Rockville, MD 20850, US; Boynton, Alton L., Andover, KS 67002, US |
74 | Representative | VTR | GLAWE DELFS MOLL Partnerschaft mbB von Patent- und Rechtsanwälten, 20148 Hamburg, DE |
| Address for service | | GLAWE DELFS MOLL Partnerschaft mbB von Patent- und Rechtsanwälten, 20103 Hamburg, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 203758 P May 12, 2000
|
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000002363139 Searchable text:
EP000002363139 Original document:
EP000002363139B1 Searchable text:
EP000002363139B1 |
43 | Date of first publication | EVT | Sep 7, 2011 |
| Date of the first transfer into DPMAregister | EREGT | Oct 21, 2011 |
| Date of the (most recent) update in DPMAregister | REGT | Aug 13, 2019 (Show all update days)(Hide all update days)- Aug 13, 2019; Mar 7, 2019; May 24, 2017; Feb 9, 2017; Jan 26, 2017; Jan 17, 2017; Apr 27, 2016; Apr 7, 2016; Mar 3, 2016; Feb 15, 2013
- Historical data not available for this/these date(s)
- Oct 21, 2011
- Date of the first transfer into DPMAregister
|